<DOC>
	<DOCNO>NCT00104663</DOCNO>
	<brief_summary>PRION-1 aim ass activity safety Quinacrine ( Mepacrine hydrochloride ) human prion disease . It also aim establish appropriate framework clinical assessment therapeutic option human prion disease refine expanded future , new agent become available .</brief_summary>
	<brief_title>PRION-1 : Quinacrine Human Prion Disease</brief_title>
	<detailed_description>The human prion disease traditionally classify Creutzfeldt-Jakob disease ( CJD ) , Gerstmann-Str√§ussler-Scheinker ( GSS ) disease kuru . They alternatively classify three causal category : sporadic , acquire inherit . The appearance new human prion disease , variant CJD ( vCJD ) , United Kingdom 1995 onwards , experimental evidence cause prion strain cause bovine spongiform encephalopathy ( BSE ) cattle , raise possibility major epidemic vCJD occur United Kingdom country result dietary exposure BSE prion . These concern lead intensified effort develop therapeutic intervention . Quinacrine previously use treat disease malaria ; however , find serious side effect longer license United Kingdom . There limited evidence laboratory test potential use quinacrine human prion disease , evidence date possible clinical benefit scarce . The PRION-1 trial undertaken since drug currently available consider suitable human evaluation .</detailed_description>
	<mesh_term>Prion Diseases</mesh_term>
	<mesh_term>Quinacrine</mesh_term>
	<criteria>Aged 12 year , diagnose type human prion disease . In coma , preterminal phase disease prolongation current quality life would support Known sensitivity quinacrine Been take putative antiprion therapy le 8 week</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Creutzfeldt-Jakob disease</keyword>
	<keyword>inherit</keyword>
	<keyword>sporadic</keyword>
	<keyword>acquire</keyword>
	<keyword>new variant CJD</keyword>
</DOC>